Lucia I Sue Selected Research

Lucia I Sue Research Topics

Disease

28	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2003
20	Dementia (Dementias) 01/2022 - 09/2003
12	Amyloid Plaque 01/2021 - 01/2007
9	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2009
5	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 04/2008
4	COVID-19 01/2022 - 01/2021
4	Synucleinopathies 01/2020 - 11/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2015
2	Cognitive Dysfunction 01/2022 - 07/2011
2	Encephalitis (Encephalitis, Rasmussen) 02/2021 - 01/2017
2	Death (Near-Death Experience) 06/2020 - 11/2011
2	Disease Progression 11/2019 - 01/2015
2	Deglutition Disorders (Dysphagia) 08/2015 - 07/2013
1	Neuroinflammatory Diseases 09/2021
1	Cerebral Infarction 02/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Obesity 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Heart Failure 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Carotid Artery Diseases 01/2019
1	Late Onset Disorders 01/2018
1	Inflammation (Inflammations) 01/2015
1	3 Progressive Supranuclear Palsy 06/2014
1	Hippocampal Sclerosis 01/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2014
1	Frontotemporal Dementia (Semantic Dementia) 01/2014
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2014
1	Pathologic Processes 07/2013
1	Essential Tremor (Essential Tremors) 01/2012
1	Vascular Diseases (Vascular Disease) 11/2011
1	Down Syndrome (Down's Syndrome) 11/2011
1	Amyloid angiopathy 11/2011
1	Atherosclerotic Plaque (Atheroma) 11/2011
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2011
1	Hallucinations (Hallucination) 07/2009
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2007

Drug/Important Bio-Agent (IBA)

15	Amyloid (Amyloid Fibrils)IBA 01/2022 - 09/2003
8	SynucleinsIBA 01/2021 - 02/2013
7	Proteins (Proteins, Gene)FDA Link 02/2021 - 09/2003
5	alpha-SynucleinIBA 01/2020 - 06/2010
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 08/2009
4	RNA (Ribonucleic Acid)IBA 09/2021 - 09/2003
4	florbetapirIBA 01/2021 - 11/2011
3	CytokinesIBA 01/2022 - 01/2015
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2020 - 04/2008
3	Amyloid beta-PeptidesIBA 01/2018 - 10/2003
3	ApolipoproteinsIBA 05/2013 - 01/2007
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2012
2	ORALIT (ORS)IBA 01/2021 - 01/2007
2	Apolipoproteins E (ApoE)IBA 01/2021 - 05/2013
2	Serine (L-Serine)FDA Link 01/2021 - 06/2014
1	alpha2 Subunit Collagen Type IIBA 09/2021
1	InterferonsIBA 09/2021
1	Apolipoprotein E4IBA 01/2021
1	florbenazine F 18IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	RadiopharmaceuticalsIBA 01/2021
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 06/2020
1	Purinergic Receptors (Receptors, Purine)IBA 01/2020
1	Neurofilament ProteinsIBA 01/2020
1	lysosomal proteinsIBA 12/2019
1	ProgranulinsIBA 12/2019
1	AnticoagulantsIBA 01/2019
1	Amino Acids FDA Link 01/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 08/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	ChemokinesIBA 01/2015
1	Retinaldehyde (Retinal)IBA 06/2014
1	Formaldehyde (Formol)FDA Link 03/2014
1	ParaffinIBA 03/2014
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2013
1	ParvalbuminsIBA 01/2012
1	Dopamine beta-HydroxylaseIBA 01/2012
1	thioflavin TIBA 01/2012
1	LigandsIBA 11/2011
1	Peptides (Polypeptides)IBA 11/2011
1	Cholinergic Agents (Cholinergics)IBA 07/2011
1	Coloring Agents (Dyes)IBA 06/2010
1	Levodopa (L Dopa)FDA LinkGeneric 07/2009
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2008
1	UbiquitinIBA 09/2003
1	Complement System Proteins (Complement)IBA 09/2003

Therapy/Procedure

4	Therapeutics 08/2015 - 07/2011
1	Denervation 01/2020
1	Sympathectomy (Sympathectomies) 01/2020